Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

B of A Securities Maintains Underperform on Herbalife, Lowers Price Target to $8

Author: Benzinga Newsdesk | March 21, 2024 01:46pm
B of A Securities analyst Anna Lizzul maintains Herbalife (NYSE:HLF) with a Underperform and lowers the price target from $10 to $8.

Posted In: HLF

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist